Mallinckrodt Denies Manipulating Acthar Market

By Rick Archer · November 17, 2021, 8:55 PM EST

Mallinckrodt closed its defense against claims it inflated the price of its Acthar gel on Wednesday, with witnesses saying that the drugmaker didn't suppress a competing product and that the speaking fees...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Related Sections

Case Information

Case Title

Mallinckrodt plc

Case Number

1:20-bk-12522

Court

Delaware

Nature of Suit

Date Filed

October 12, 2020